Related Experiment Video
Updated: Aug 9, 2026

Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats
Published on: November 8, 2018
Pyridoxine-dependent seizures and cognition in adulthood
Kathleen Baynes1, Sarah Tomaszewski Farias, Sidney M Gospe
1Department of Neurology, Center for Neurosciences, University of California, Davis, CA, USA.
Insights
Pyridoxine-dependent epilepsy, a rare neonatal seizure disorder, was treated early in this patient. Despite prompt intervention, long-term evaluation revealed mild intellectual disability and specific cognitive deficits.
Area of Science:
- Neurology
- Genetics
- Developmental Pediatrics
Background:
- Pyridoxine-dependent epilepsy (PDE) is a rare inherited metabolic disorder causing intractable seizures in newborns.
- It results from a deficiency in the enzyme ALDH7A1, leading to accumulation of toxic metabolites.
- Early diagnosis and treatment with pyridoxine (vitamin B6) are crucial for seizure control.
Observation:
- A male infant presented with neonatal onset seizures and was treated with pyridoxine within 8 hours of birth.
- Neuropsychological evaluation at age 37 and MRI at age 31 were performed.
- The patient exhibited a significant Performance IQ advantage over Verbal IQ, with impaired expressive language skills.
Findings:
- The patient's Full-Scale IQ was 71, Verbal IQ was 64, and Performance IQ was 85.
- MRI revealed characteristic thinning of the posterior corpus callosum.
- Despite early and continuous pyridoxine treatment, the patient developed mild mental retardation.
Implications:
- This case highlights that even with early treatment, individuals with pyridoxine-dependent epilepsy may experience cognitive deficits.
- The consistent findings across cases suggest a shared underlying mechanism for structural brain changes and cognitive profiles in PDE.
- Further research into the neurobiological impact of ALDH7A1 deficiency is warranted to improve long-term outcomes.
Abstract:
A case report of neonatal onset pyridoxine-dependent seizures in a male patient with early diagnosis and treatment is presented. The patient's epilepsy was recognized and treated with pyridoxine (vitamin B6) within 8 hours of birth. Treatment has been nearly continuous since that time. This paper reports the results of a full neuropsychological evaluation at age 37 years and MRI completed at age 31 years. Consistent with other case reports in the literature, there was a significant Performance IQ (PIQ) advantage with decreased Verbal IQ (VIQ) and expressive language skills (Full-Scale IQ 71, VIQ 64, PIQ 85). MRI demonstrated characteristic thinning of the posterior corpus callosum. This report provides an example of early treatment that nonetheless results in a mild mental retardation. The similarity of the structural changes on MRI and the cognitive profile of this patient to those of others reported in the literature suggest that the underlying mechanism for both may be the same.
Related Concept Videos
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Pharmacodynamics in Geriatric Patients: Effects of Age
Cognitive Development During Adulthood

